ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.042,00
0,18%
S&P 500
6.033,65
0,62%
Dow Jones
43.916,93
0,99%
Euro vs US Dollar
1,04188
-0,02%
Bitcoin
104.983,75
2,90%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Intra Cellular Therapies Inc (ITCI)

  7. Intra Cellular Therapies Inc (ITCI) News

ITCI

Intra Cellular Therapies (ITCI)

Intra Cellular Therapies Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ITCI
DatumZeitQuelleÜberschriftSymbolFirma
13/01/202523h27Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ITCIIntra Cellular Therapies Inc
13/01/202513h48Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ITCIIntra Cellular Therapies Inc
13/01/202513h47Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ITCIIntra Cellular Therapies Inc
13/01/202512h32GlobeNewswire Inc.Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.NASDAQ:ITCIIntra Cellular Therapies Inc
13/01/202512h30Business WireJohnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.NASDAQ:ITCIIntra Cellular Therapies Inc
10/01/202512h46Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ITCIIntra Cellular Therapies Inc
10/01/202512h30GlobeNewswire Inc.Intra-Cellular Therapies Settles CAPLYTA® (lumateperone) Patent Litigation with Sandoz NASDAQ:ITCIIntra Cellular Therapies Inc
06/01/202514h00GlobeNewswire Inc.Intra-Cellular Therapies to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ITCIIntra Cellular Therapies Inc
11/12/202414h00GlobeNewswire Inc.Intra-Cellular Therapies Presents Data from the CAPLYTA Adjunctive MDD Phase 3 Program at the American College of Neuropsychopharmacology Annual MeetingNASDAQ:ITCIIntra Cellular Therapies Inc
07/12/202400h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITCIIntra Cellular Therapies Inc
05/12/202422h27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ITCIIntra Cellular Therapies Inc
04/12/202422h18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ITCIIntra Cellular Therapies Inc
03/12/202413h38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ITCIIntra Cellular Therapies Inc
03/12/202413h30GlobeNewswire Inc.Intra-Cellular Therapies Submits Supplemental New Drug Application (sNDA) to FDA for CAPLYTA® (lumateperone) for the Treatment of Major Depressive Disorder as Adjunctive TherapyNASDAQ:ITCIIntra Cellular Therapies Inc
19/11/202414h00GlobeNewswire Inc.Intra-Cellular Therapies to Participate in Three Upcoming Investor ConferencesNASDAQ:ITCIIntra Cellular Therapies Inc
08/11/202423h31Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ITCIIntra Cellular Therapies Inc
07/11/202414h00GlobeNewswire Inc.Intra-Cellular Therapies Announces Presentations at the 2024 Psych Congress and NEI CongressNASDAQ:ITCIIntra Cellular Therapies Inc
05/11/202413h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ITCIIntra Cellular Therapies Inc
05/11/202413h00GlobeNewswire Inc.Intra-Cellular Therapies Announces Positive Topline Results in Phase 3 Trial Evaluating CAPLYTA for the Prevention of Relapse in Patients with SchizophreniaNASDAQ:ITCIIntra Cellular Therapies Inc
30/10/202412h53Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ITCIIntra Cellular Therapies Inc
30/10/202412h44Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ITCIIntra Cellular Therapies Inc
30/10/202412h30GlobeNewswire Inc.Intra-Cellular Therapies Reports Third Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 Caplyta Sales GuidanceNASDAQ:ITCIIntra Cellular Therapies Inc
24/10/202420h02Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ITCIIntra Cellular Therapies Inc
17/10/202414h00GlobeNewswire Inc.Intra-Cellular Therapies to Host Third Quarter 2024 Financial Results Conference Call and WebcastNASDAQ:ITCIIntra Cellular Therapies Inc
23/09/202414h00GlobeNewswire Inc.Intra-Cellular Therapies Announces Presentations at the 2024 European College of Neuropsychopharmacology CongressNASDAQ:ITCIIntra Cellular Therapies Inc
06/09/202423h43Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ITCIIntra Cellular Therapies Inc
31/08/202400h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITCIIntra Cellular Therapies Inc
30/08/202422h06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ITCIIntra Cellular Therapies Inc
29/08/202422h34Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ITCIIntra Cellular Therapies Inc
29/08/202400h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITCIIntra Cellular Therapies Inc
 Showing the most relevant articles for your search:NASDAQ:ITCI

Kürzlich von Ihnen besucht

TG
BAYN
Bayer
TG
MBG
MercedesBenz
USOTC
BASFY
BASF (QX)
COIN
ETHUSD
Ethereum
COIN
XRPUSD
Ripple
NYSE
NKE
Nike
CCOM
SILVER
SILVER
NYSE
DIS
Walt Disney
NASDAQ
MSFT
Microsoft
DBI
SDXP
SDAX
USOTC
ADDYY
Adidas (QX)
CCOM
US30
US 30
TG
TUI1
Tui
DBI
TDXP
Tec DAX
NASDAQ
AAPL
Apple
PM
XAUUSD
Gold vs US Dollar
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten